Search research articles
Contact Us
Filters
Showing results (31-40 of 119) with videos related to
Page
of 12
Sort By:
Bone Marrow Transplantation
|
April 10, 2019
Pre-hematopoietic cell transplant Ruxolitinib in patients with primary and secondary myelofibrosis
Rachel B Salit, Bart L Scott, Emily A Stevens, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 22, 2020
Early Mixed Lymphoid Donor/Host Chimerism is Associated with Improved Transplant Outcome in Patients with Primary or Secondary Myelofibrosis
H Joachim Deeg, Rachel B Salit, Tim Monahan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 19, 2012
Pretransplantation therapy with azacitidine vs induction chemotherapy and posttransplantation outcome in patients with MDS
Aaron T Gerds, Ted A Gooley, Elihu H Estey, et al.
Haematologica
|
February 18, 2017
Mutational analysis in serial marrow samples during azacitidine treatment in patients with post-transplant relapse of acute myeloid leukemia or myelodysplastic syndromes
Janghee Woo, Nicholas P Howard, Barry E Storer, et al.
Transplantation and Cellular Therapy
|
September 15, 2025
Pre-Hematopoietic Cell Transplantation Ruxolitinib in Transplantation-Eligible Patients with Myelofibrosis: Long-Term Outcomes of a Phase II Prospective Study
Rachel B Salit, Xinyi Fan, Ted A Gooley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 12, 2016
Minimal Identifiable Disease and the Role of Conditioning Intensity in Hematopoietic Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Evolving from Myelodysplastic Syndrome
Moreno Festuccia, H Joachim Deeg, Theodore A Gooley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 9, 2015
Relapse after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes: Analysis of Late Relapse Using Comparative Karyotype and Chromosome Genome Array Testing
Cecilia C S Yeung, Aaron T Gerds, Min Fang, et al.
Haematologica
|
October 22, 2013
Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II study
Roland B Walter, Bruno C Medeiros, Kelda M Gardner, et al.
Science Translational Medicine
|
May 13, 2016
Delayed globin synthesis leads to excess heme and the macrocytic anemia of Diamond Blackfan anemia and del(5q) myelodysplastic syndrome
Zhantao Yang, Siobán B Keel, Akiko Shimamura, et al.
Bone Marrow Transplantation
|
December 14, 2019
Diagnosis of pulmonary hypertension by noninvasive methods in hematopoietic cell transplant patients with myelofibrosis
Rachel B Salit, Kelsey K Baker, Rachael Edwards, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 119) with videos related to
Sort By:
Page
of 12
Bone Marrow Transplantation
|
April 10, 2019
Pre-hematopoietic cell transplant Ruxolitinib in patients with primary and secondary myelofibrosis
Rachel B Salit, Bart L Scott, Emily A Stevens, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 22, 2020
Early Mixed Lymphoid Donor/Host Chimerism is Associated with Improved Transplant Outcome in Patients with Primary or Secondary Myelofibrosis
H Joachim Deeg, Rachel B Salit, Tim Monahan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 19, 2012
Pretransplantation therapy with azacitidine vs induction chemotherapy and posttransplantation outcome in patients with MDS
Aaron T Gerds, Ted A Gooley, Elihu H Estey, et al.
Haematologica
|
February 18, 2017
Mutational analysis in serial marrow samples during azacitidine treatment in patients with post-transplant relapse of acute myeloid leukemia or myelodysplastic syndromes
Janghee Woo, Nicholas P Howard, Barry E Storer, et al.
Transplantation and Cellular Therapy
|
September 15, 2025
Pre-Hematopoietic Cell Transplantation Ruxolitinib in Transplantation-Eligible Patients with Myelofibrosis: Long-Term Outcomes of a Phase II Prospective Study
Rachel B Salit, Xinyi Fan, Ted A Gooley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 12, 2016
Minimal Identifiable Disease and the Role of Conditioning Intensity in Hematopoietic Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Evolving from Myelodysplastic Syndrome
Moreno Festuccia, H Joachim Deeg, Theodore A Gooley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 9, 2015
Relapse after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes: Analysis of Late Relapse Using Comparative Karyotype and Chromosome Genome Array Testing
Cecilia C S Yeung, Aaron T Gerds, Min Fang, et al.
Haematologica
|
October 22, 2013
Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II study
Roland B Walter, Bruno C Medeiros, Kelda M Gardner, et al.
Science Translational Medicine
|
May 13, 2016
Delayed globin synthesis leads to excess heme and the macrocytic anemia of Diamond Blackfan anemia and del(5q) myelodysplastic syndrome
Zhantao Yang, Siobán B Keel, Akiko Shimamura, et al.
Bone Marrow Transplantation
|
December 14, 2019
Diagnosis of pulmonary hypertension by noninvasive methods in hematopoietic cell transplant patients with myelofibrosis
Rachel B Salit, Kelsey K Baker, Rachael Edwards, et al.
Page
of 12